RevivBio
Cambridge, United States · $3.4M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1–10
- Business Model
- B2B
- Website
- revivbio.com
- Total Funding
- $3.4M
- Last Round
- $3.0M SeedDec 2023
- Rounds
- 2
About
Biotech company using protein engineering and advanced microfluidics to develop innovative life sciences products.
Summary
RevivBio is a Biotech company based in Cambridge, United States. It has raised $3.4M in total across 2 rounds, most recently a $3.0M Seed round in Dec 2023. Investors include Alumni Ventures, Seventure Partners and US National Science Foundation.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Dec 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...